HCA Healthcare, Inc. HCA
NYSE · XNYS · stock · Services-General Medical & Surgical Hospitals, NEC
Chart by TradingView
7/9
Piotroski F — financial health
—
Altman Z″ — distress risk
10.0%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $75.6B | $6.8B | — | $7.7B | -$2.8B |
| 2024 | $70.6B | $5.8B | — | $5.6B | $555.0M |
| 2023 | $65.0B | $5.2B | — | $4.7B | $1.1B |
| 2022 | $60.2B | $5.6B | — | $4.1B | -$73.0M |
| 2021 | $58.8B | $7.0B | — | $5.4B | $1.5B |
| 2020 | $51.5B | $3.8B | — | $6.4B | $2.9B |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Source: SEC EDGAR filings · CIK 0000860730 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.